Recurring Features
The fixtures you can count on — every Monday, every month, every quarter. The cadence that keeps you ahead, on a schedule you can plan around.
The Monday Brief — Week of Jul 15, 2026
InMode faces a takeover battle, Botox pricing enters the negotiation room, and RF platforms race for dominance—here's what to watch.
WeeklyThe Monday Brief — Week of Jul 12, 2026
InMode takeover drama, margin pressure from big brands, and a new player entering the toxin market—what owners need to watch this week.
WeeklyThe Monday Brief: Week of Jul 05, 2026
Galderma's Botox rival stumbles at FDA; Allergan expands with neck approval; InMode faces takeover drama; and the market signals what's working.
WeeklyThe Monday Brief — Week of Jun 28, 2026
Skinvive expands, Allergan signals margin pressure, InMode in play, and the GLP-1 side-effect story deepens—what owners need to watch.
MonthlyMonthly Regulatory Roundup — July 2026
Fourteen new device clearances, a compounding recall, and incoming FDA scrutiny of dermal fillers—here's what you need to know and do right now.
MonthlyMonthly Regulatory Roundup — June 2026
Twelve new device clearances, a critical compounding recall, and the FDA's formal dermal filler review process kicks off. Here's what you need to know and do.
QuarterlyQuarterly Device Clearance Digest — Q3 2026
Twelve FDA 510(k) clearances, three major corporate signals, and a landscape shift toward LED and energy-based platforms.
QuarterlyQuarterly Device Clearance Digest — Q2 2026
Sixteen FDA 510(k) clearances, three major vendor signals, and a clinical trial landscape shift shape the aesthetic device market this quarter.
QuarterlyQuarterly Pricing Pulse — Q3 2026
Injectable, filler, and treatment pricing shifted sharply this quarter. Here's what moved, why it matters, and how to protect your margins.
QuarterlyQuarterly Pricing Pulse — Q2 2026
Botox/Juvéderm rebate wars, Jeuveau aggression, and GLP-1 margin squeeze reshape injectable economics—here's what moved and how to protect your bottom line.
AnnualYear in Aesthetics — 2026
A bellwether year of pricing wars, blockbuster device launches, regulatory expansion, and the consolidation that will reshape independent practices.